Bioactive Libraries

Diversity Libraries

Product name
Description
Download
Price

CLOUD

CLOUD-293

293 compounds

Description

Represents the diversity of structures and molecular targets of all FDA-approved chemical entities (Nat Chem Biol 13 (2017), 771–778)

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

FDA approved drugs

FAD-1040

1 040 compounds

Description

Most relevant selection of drugs in one formulation/no duplicates. Contains WHO List of Essential Medicines including Lapatinib and latest approved drugs such as Tivozanib, etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Bioactive Library

BRL-2320

2 320 compounds

Description

Actives with extensive target classes’ coverage and the broadest possible therapeutic areas applications – from CNS agents and anti-infectives to anticancer drugs, steroids and molecular glues.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Phenotypic Screening Library

PSL-5760

5 760 compounds

Description

Library of cell penetrating compounds and their closest analogs. Covers diverse therapeutic areas from antitumor, neurology and antibacterial to aging diseases.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

PAINS Library

PAINS-320

320 compounds

Description

Frequent hitters with most diverse scaffold selection – from small hydroquinone and other covalent modifiers to polyfluorinated highly lipophilic molecules and dyes.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Focused Sets

Target / Therapeutic Area
Description
Download
Price

Angiogenesis

184 compounds

Description

Angiogenesis related ligands targeting FLT3, DYRK1A, Collagenase 3, GAK, Bcr-Abl, BTK, EGFR etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Apoptosis

38 compounds

Description

Apoptosis related ligands targeting Mdm2 Mcl-1 IAP Caspase Modulator I, Caspase 3 and Caspase 6, Bcl-2, p53, TNF-alpha.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cancer Immunology

390 compounds

Description

Molecules used for immune-oncology research targeting P2X3 receptor MAG lipase, PI3 kinase and P2Y12.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cell Cycle

94 compounds

Description

Сell cycle related compounds, e.g. LDC000067 CDK12-In-2 and Palbociclib selective and pan-CDK inhibitors, ROCK, mTOR and Aurora kinase inhibitors.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Epigenetics

158 compounds

Description

Epigenetics related compounds targeting HDACs, HMT, JMJD, DNMT, Bromodomains, i KDM5 inhibitors and Sirtuin.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

GPCRs

738 compounds

Description

Bioactive GPCR-targeted molecules, including GPCR inhibitors, agonists, and allosteric modulators. Library represents actives against 195 unique GPCR targets.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Growth Factors Cytokines

130 compounds

Description

Growth factors and cytokines ligands, including Ceritinib ALK inhibitor, Lucitanib VEGFR and FGFR inhibitor, MSX-127 CXCR4 antagonist, Eltrombopag Thrombopoietin receptor agonist etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Ion Channels

300 compounds

Description

Ligands with annotated activity against 6 ion channel families and 105 unique targets. The library covers major applications typical for ion channel: cardiovascular regulation, neuroscience, immune response regulation.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

JAK-STAT

104 compounds

Description

JAK-STAT signalling targeted molecules, including Pazopanib multi-TK inhibitor, LY294002 TPK inhibitor, PF06700841 JAK1 inhibitor, SH-4-54 STAT3 inhibitor and other related actives.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Kinases

366 compounds

Description

Kinase binders, including approved drugs Imatinib, covalent Ibrutinib, Dasatinib and highly active inhibitors of most important kinases such as RAF, MAPK, BTK and many other.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Membrane Receptors

745 compounds

Description

Membrane receptors ligands, including Risperidone (5-HT2 receptor blocker, D2 receptor antagonist), VU0071063 (ATP-dependent potassium channel activator), CU-T12-9 (TLR1/2 antagonist), LY354740 (mGlu2/3 receptor agonist).

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Nuclear Hormone Receptors

160 compounds

Description

Nuclear receptor ligands with referenced activity against 368 unique molecular targets, including agonists Dienogest, antagonists Darolutamide, inverse antagonists GSK805.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Protease Inhibitors

175 compounds

Description

High activity ligands against 104 human and pathogenic proteases, including Saxagliptin, anti-diabetic type 2 drug, Mpro SARS-CoV-2 inhibitors, Atazanavir HIV-1 protease inhibitor etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Signal Transduction

254 compounds

Description

Signal transduction related ligands, including Selatinib EGFR/HER-2 inhibitor, XAV-939 Tankyrase1/2 inhibitor, STING agonist-1 G10, Fedratinib broad spectrum kinase inhibitor etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

Transporters

169 compounds

Description

Molecules with annotated activity against 12 transporter families and 82 unique targets, including Paroxetine (serotonin reuptake inhibitor), ML-352 (choline transporter 1 inhibitor, AR- C155858 (MCT1 and MCT2 inhibitor, GABA receptor ligands etc.

Download file

Price

This email address is being protected from spambots. You need JavaScript enabled to view it.

FOLLOW US

Contact us

I have read and agree with Privacy Policy of Enamine

Send me details